BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1783208)

  • 21. On the possible in vitro use of perfluoro compounds as oxygen reservoir for the microsomal monooxygenase system.
    Brown NA; Netter KJ; Bridges JW
    Biochem Pharmacol; 1979 Sep; 28(18):2850-2. PubMed ID: 115475
    [No Abstract]   [Full Text] [Related]  

  • 22. The liver microsomal hydroxylation enzyme system. Induction and properties of the functional components.
    Lu AY; Kuntzman R; Conney AH
    Front Gastrointest Res; 1976; 2():1-31. PubMed ID: 819342
    [No Abstract]   [Full Text] [Related]  

  • 23. Engineered yeast cells as model to study coupling between human xenobiotic metabolizing enzymes. Simulation of the two first steps of benzo[a]pyrene activation.
    Gautier JC; Urban P; Beaune P; Pompon D
    Eur J Biochem; 1993 Jan; 211(1-2):63-72. PubMed ID: 8425552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of liver microsomal cytochrome P450 in cynomolgus monkeys.
    Bullock P; Pearce R; Draper A; Podval J; Bracken W; Veltman J; Thomas P; Parkinson A
    Drug Metab Dispos; 1995 Jul; 23(7):736-48. PubMed ID: 7587963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in microsomal drug metabolism and heme oxygenase activity in isolated hepatic parenchymal and sinusoidal cells in Murphy-Sturm lymphosarcoma-bearing rats.
    Schacter BA; Kurz P
    Clin Invest Med; 1986; 9(3):150-5. PubMed ID: 3093126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NADPH-dependent production of oxy radicals by purified components of the rat liver mixed function oxidase system. II. Role in microsomal oxidation of ethanol.
    Winston GW; Cederbaum AI
    J Biol Chem; 1983 Feb; 258(3):1514-9. PubMed ID: 6296102
    [No Abstract]   [Full Text] [Related]  

  • 27. Menadione inhibition of benzo(a)pyrene metabolism in whole cells, microsomes and reconstituted systems.
    Sadowski IJ; Wright JA; Ollmann D; Israels LG
    Int J Biochem; 1986; 18(6):565-8. PubMed ID: 3709938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of ethinyl estradiol on bile secretion and liver microsomal mixed function oxidase system in the mouse.
    Tritapepe R; Di Padova C; Chiesara E; Cova D
    Biochem Pharmacol; 1980 Mar; 29(5):677-80. PubMed ID: 20227937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of some monooxygenase activities and solubilization of hepatic cytochrome P-450 in two species of freshwater fish, the nase (Chondrostoma nasus) and the roach (Rutilus rutilus).
    Monod G; Devaux A; Rivière JL
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1987; 88(1):83-9. PubMed ID: 2890492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug metabolism in rat colon: resolution of enzymatic constituents and characterization of activity.
    Oshinsky RJ; Strobel HW
    Mol Cell Biochem; 1987 May; 75(1):51-60. PubMed ID: 3114616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microsomal mixed-function oxidase activity and senescence-I. Hexobarbital sleep time and induction of components of the hepatic microsomal enzyme system in rats of different ages.
    Baird MB; Nicolosi RJ; Massie HR; Samis HV
    Exp Gerontol; 1975 Apr; 10(2):89-99. PubMed ID: 805710
    [No Abstract]   [Full Text] [Related]  

  • 32. Resorufin inhibits the in vitro metabolism and mutagenesis of benzo(a)pyrene.
    Jablonski JE; Sullivan PD
    Biochem Biophys Res Commun; 1986 Apr; 136(2):555-62. PubMed ID: 2423085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cycloheximide-induced changes in levels & distribution of hepatic microsomal enzymes of suckling rats.
    Devasagayam TP; Pushpendran CK; Eapen J
    Indian J Exp Biol; 1980 Jun; 18(6):627-30. PubMed ID: 6777294
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro inhibition of the metabolism and mutagenicity of benzo(a)pyrene and benzo(a)pyrene-7,8-dihydrodiol by naphthazarin and other naphthol derivatives.
    Espino PC; Sullivan PD
    Biochem Biophys Res Commun; 1987 Feb; 142(3):939-46. PubMed ID: 2435285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of the activities of the hepatic and renal mixed function oxidase (MFO) systems in rats during different postnatal periods of life].
    Czekaj P; Plewka A
    Folia Med Cracov; 1990; 31(3):225-36. PubMed ID: 2129035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of liver microsomal mixed-function oxidases by volatile hydrocarbons.
    Cinti DL; Lemelin MA; Christian J
    Biochem Pharmacol; 1976 Jan; 25(1):100-3. PubMed ID: 814904
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of galactosamine on rat liver cytochrome P-450 activities.
    Murase T; Masuda R; Aoi K; Sawamura T; Shiozaki Y; Sameshima Y
    Jpn J Pharmacol; 1985 Feb; 37(2):151-8. PubMed ID: 3923242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The reconstitution of hepatic microsomal mixed function oxidase activity with fractions derived from weanling rats fed different levels of protein.
    Nerurkar LS; Hayes JR; Campbell TC
    J Nutr; 1978 Apr; 108(4):678-86. PubMed ID: 416184
    [No Abstract]   [Full Text] [Related]  

  • 39. Mechanism of induction of hepatic drug-metabolizing enzymes by ethanol-I. Limited role of microsomal phospholipids.
    Joly JG; Hétu C; Mavier P; Villeneuve JP
    Biochem Pharmacol; 1976 Sep; 25(17):1995-2001. PubMed ID: 825124
    [No Abstract]   [Full Text] [Related]  

  • 40. The mechanistic plurality of cytochrome P-450 and its biological ramifications.
    Capdevila J; Saeki Y; Falck JR
    Xenobiotica; 1984; 14(1-2):105-18. PubMed ID: 6326392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.